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Abstract 
Virulence genes of Agrobacterium tumefaciens are transcriptionally activated in response to phenolic compounds and certain sugars. The transcrip- 
tional activator Vi& specifically binds to fragments containing the conserved vir box sequence present in the promoter region of all vir genes. This 
study shows that both the vir box as well as specific nonconserved sequences downstream of the vir box are required for VirG binding and 
transcriptional activation. Insertion of the identified VirG binding site into the lac promoter esulted in transcriptional activation of this heterologous 
promoter in response to the plant phenohc signal molecule acetosyringone. 
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1. Introduction 
Agrobacterium tumefaciens causes crown gall disease 
on a wide variety of dicotyledonous and some monocot- 
yledonous plants by the transfer of procaryotic DNA 
(T-DNA) from a large tumor-inducing (Ti) plasmid to 
the plant genome (reviewed in [l]). The infection process 
requires the expression of genes located both on the bac- 
terial chromosome (chv genes) and on the Ti-plasmid (vir 
genes). The vir genes are transcriptionally activated in 
response to phenolic compounds such as acetosyringone 
[2] and certain sugars which are released by wounded 
plant tissue [3,4]. 
Two of the vir genes, virA and virG, are required for 
the expression of all of the vir genes [5]. Previous studies 
have demonstrated that the corresponding ene products 
are members of a family of two component regulatory 
systems which regulate the response of bacterial cells to 
their environment via a cascade of phosphorylation reac- 
tions (reviewed in [6]). The sensor protein VirA acts as 
a kinase [7,8] whereas VirG functions as a transcriptional 
regulator of the vir genes similar to most of the response 
regulator proteins [9]. 
The Agrobacterium vir genes are characterized by one 
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Abbreviations: lacp, lac promoter; VB, vir box sequence; VBl5, VBlI9, 
VB/34, sequence comprising the virE vir box and 519, or 34 nucleotides 
3’ to the vir box. 
or more conserved dodecadeoxynucleotide sequences 
(vir box) in the promoter region [lo]. At least one of the 
vir boxes of each operon is required for transcriptional 
activation in response to acetosyringone [l l-141, and the 
VirG protein was shown to specifically bind to fragments 
containing this cis acting regulatory sequence [ 12,15,16]. 
Ba131 deletion analysis revealed that sequences upstream 
of the vir box sequences could be removed without affect- 
ing induction of the vir genes [ 11, 121 
In the present study we show that the vir box is not 
sufficient for binding of the VirG protein, but requires 
additional specific nonconserved sequences 3’ to the vir 
box. We further show that the presence of the VirG 
binding site results in transcriptional activation of the E. 
coli fat promoter in response to acetosyringone. 
2. Materials and methods 
2.1. Bacterial strains 
A. tumefaciens strain A348 is a derivative of strain Al36 containing 
the octopine-catabolizing plasmid pTiA6 [17]. A. tumefaciens strains 
Mx321 and Al030 carry mutations in the virG and virA genes, respec- 
tively [IS]. 
2.2. Plasmids and plasmid constructions 
Plasmid pSG673 [19] contains a truncated virA gene under the con- 
trol of the luc promoter and plasmid pSG675 [12] contains the virE 
gene. 
The virE vir box (TGCAGTTGAAAC) was inserted into the lac 
promoter of plasmid pSG673 at position -54 (with respect to the 
transcriptional start site) by oligonucleotide directed site specific mut- 
agenesis [20] resulting in plasmid pRS3220 (VB:lacp). 
Fragments from the virE promoter containing the vir box plus 5 and 
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19 additional nucleotides at their 3’ end, designated VBIS and VB/19 
(see Fig. l), were subcloned into the luc promoter as follows. A SmaI 
restriction site was introduced into the lac promoter on plasmid 
pSG673 at position -31 by oligonucleotide directed site specific mut- 
agenesis resulting in plasmid pRS9812. This restriction enzyme site was 
used to subclone a SmaI-EcoRV (about 500 bp) and a AvaI fragment, 
blunt ended with Klenow polymerase (about 520 bp) from plasmid 
pSG675 [12] to construct plasmids pRR1340 (VBIs:lacp) and pRS9902 
(VB/19:lacp). The 5’ Avul and SmaI sites used for subcloning are lo- 
cated within the same polylinker and thus the two fragments share 
identical sequences upstream of the vir box. The positions of the vir box 
in the modified lac promoter of the plasmids pRS3220 (VB:lacp) and 
pRS9902 (VBlYllucp) were the same as in the virE promoter with 
respect o the transcriptional start site (nucleotides -65 to -54). 
Fragments were subcloned into the broad host range vector pUCD2 
[21] and a fusion of the lac promoter constructs with the 1ac.Z coding 
region was constructed as follows. The truncated virA gene under con- 
trol of the native and modified luc promoter in plasmids pSG673, 
pRS3220, pRRl340 and pRS9902 were subcloned as PvuIILAsp718 
fragments into the vector pUCD2 which had been cut with the same 
enzymes resulting in plasmids pRS4724, pRS4602, pRR1605 and 
pRS10001, respectively. Fusions of the wildtype lac promoter and the 
modified lac promoter with the IacZ coding region were constructed by 
substituting the truncated virA gene for the 1ac.Z coding region. The 
BgBILAsp718 fragments with the truncated virA gene from pRS4724, 
pRS4602, pRR1605 and pRSlOOO1 were substituted for a BamHIL 
Asp718 fragment from plasmid pRS8102 (a derivative of pMC1402 [22] 
with a unique Asp718 site 3’ of the 1ac.Z coding region; Roitsch and 
Nester, unpublished), resulting in plasmids pRS8501 (J&C), pRS8401 
(VB:p/ac), pRR2001 (VB/S:plac) and pRS10201 (VB/IY:plac), respec- 
tively. 
The vir box of the virE promoter on plasmid pSG675 was deleted by 
oligonucleotide directed site specific mutagenesis resulting in plasmid 
pRS2013. The virE vir box was reinserted at the wild type position but 
in inverse orientation into the mutated virE promoter on plasmid 
pRS2013 by oligonucleotide directed site specific mutagenesis to con- 
struct plasmid pRS3324. 
Plasmid pRS3420 was constructed by deleting 13 bp downstream of 
the vir box of the virA promoter on plasmid pSW169 by oligonucleotide 
directed site specific mutagenesis. Thus the virA vir box was moved to 
the position of the virE vir box with respect o the transcriptional start 
site. 
A schematic representation of the various promoter constructs de- 
scribed above is shown in Fig. 2. 
All mutations created by oligonucleotide directed site specific mut- 
agenesis were confirmed by DNA sequence analysis [23]. 
2.3. Other methods 
Protein binding assays using two complementary 12 bp oligonucle- 
otides, TGCAATTGAAAC and GTTTCAATTGCA, representing 
both strands of the vir box consensus equence were carried out as 
follows. The oligonucleotides were end labeled by T4-DNA-kinase 
using [y-“P]ATP. The two oligonucleotides were annealed by incuba- 
tion of equimolar amounts at 90°C for 5 min and slowly cooling the 
assay to room temperature. In each binding assay 10,000 cpm of labeled 
oligonucleotides (5 ng) were used with different amounts of purified 
VirG protein overproduced in E. coli [12]. The conditions for binding 
and electrophoresis as well as the conditions for the binding assays 
using DNA restriction fragments from the various promoter constructs 
were the same as described previously [12]. 
Other techniques were carried out according to published proce- 
dures: These included induction assays and western (immuno-) blot 
analysis [24]. . 
3. Results 
3.1. Binding of VirG requires speciJic nonconserved 
sequences in addition to the conserved vir box 
Previous gel retardation assays demonstrated that the 
transcriptional activator VirG specifically binds to vir 
gene promoter fragments and DNA footprinting analy- 
ses revealed that the conserved vir box sequences are 
specifically protected by VirG [12,15]. Since fragments 
with large flanking sequences were used in these studies 
we wanted to determine whether the vir box sequence 
alone was sufficient for binding of the regulatory protein 
VirG. We carried out a gel retardation experiment using 
two complementary 12mer oligonucleotides representing 
the vir box consensus sequence, TGCAATTGAAAC 
[lo], as a double stranded probe. The addition of VirG 
did not result in a retarded band indicating that VirG did 
not bind to the double stranded oligonucleotide probe 
(not shown). Thus the vir box sequence lacking any 
flanking sequences is not sufficient for VirG binding. 
Since it has been shown in other systems that regulatory 
proteins are able to bind to oligonucleotides representing 
the binding sequence [25,26] this result indicated that 
VirG binding requires sequences in addition to the con- 
served vir box, 
Ba131 deletion analysis from the virE [ 121 and virB [ 1 l] 
promoter demonstrated previously that sequences 5’ of 
the vir box could be deleted without affecting transcrip- 
tional activation. These results indicate that sequences 5’ 
of the vir box are not important for binding of the regu- 
latory protein. Therefore we tested the binding of the 
VirG protein to the virE promoter fragments with the vir 
box and 5, 19 or 34 additional nucleotides 3’ to the virE 
vir box (VB/5, VB/19, and VB/34) at their 3’ end (Fig. 1). 
The DNA binding assay shown in Fig. 3A revealed that 
the VirG protein bound only to the fragments containing 
19 and 34 additional nucleotides downstream of the vir 
box. This result shows that the VirG binding site of the 
vir promoter comprises both the vir box and additional 
nucleotides 3’ to the vir box. Using the VB/34 fragment 
a better retardation is visible compared to VB/19 with 0.2 
pug VirG protein. This may be due to the fact the binding 
sites are located at the very 3’ end of the fragments used 
for this experiment. Alternatively, it may be possible that 
the VB119 sequence contains only a partial binding site 
whereas the VB/34 sequence contains a complete binding 
site. Our previous DNA footprinting analysis using the 
virE promoter fragments revealed that not only the vir 
box but also flanking sequences were protected by VirG 
[12], which indicates that sequences on both sites of the 
vir box are at least in contact with virG. Therefore better 
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Fig. 1. Schematic representation of the promoter region of the virE 
promoter. The 3’ restriction enzyme sites used for subcloning and to 
generate fragments for the gel retardation experiment shown in Fig. 3A 
are indicated. The arrows indicate the position of a palindromic se- 
quence; Ts: transcriptional start site. 
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vir box sequence are required for VirG binding and tran- 
scriptional activation of the vir genes was supported by 
additional experiments. We have constructed a mutant 
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Fig. 2. Schematic representation of the various promoter constructs B 
used in this study and the designation of the corresponding plasmid 
constructs. The figures are not drawn to scale. 
binding to the VBl34 fragment may be due to unspecific 
stabilization of the binding to the binding site located 
within the VBl19 sequence. 
To address the question of whether specific sequences 
3’ of the vir box are required for VirG binding and to 
gain additional insight into the number of nucleotides 
required for binding we have introduced the 12 bp vir 
box sequence and a fragment with the VB/Z9 sequence 
into the luc promoter. In each construct the vir box was 
inserted at the same position as in the virE promoter with 
respect to the transcriptional start site (nucleotides -65 
to -54). Gel retardation experiments were carried out to 
assay the binding of VirG to DNA fragments derived 
from the wild type lac promoter and constructs with the 
modified luc promoters. Fig. 3B demonstrates that VirG 
specifically binds only to fragments derived from the lac 
promoter with the VB/Z9 sequence. The VirG protein did 
not bind to the wildtype luc promoter nor to the Zac 
promoter with the 12 bp vir box sequence. 
These findings demonstrate that the VirG binding site 
has a complex structure and consists of both of the con- 
served vir box sequence and specific nonconserved se- 
quences 3’ of the vir box. Thus, the VBl19 sequence is 
necessary and sufficient for VirG binding and the bind- 
ing site is either identical to this sequence or located 
within this sequence. 
The result that specific sequences downstream of the 
Fig. 3. Effect of sequences 3’ to the virE vir box on VirG binding (A) 
Binding of the VirG protein to virE promoter fragments with the vir 
box and 5, 19 or 34 additional nucleotides 3’ of the vir box at their 3’ 
end. The experiment was carried out using following fragments from 
plasmid pSG675: Lanes l-3, San-EcoRV fragment (144 bp; VB/5 se- 
quence at the 3’ end); lanes 46, San-AvaI fragment (160 bp; VB/19); 
lanes 7-9, San-RsaI fragment (174 bp; VB/34). Lanes 1, 4 and 7, no 
protein; lanes 2, 5 and 8, 0.2 pg VirG protein; lanes 3, 6 and 9, 1.0 ,ug 
VirG protein. R, retarded band. (B) Binding of the VirG protein to 
fragments from the Zac promoter and vir box lac promoter constructs. 
Lanes 1 and 2, PvuII-BamHI fragment from pSG673 (250 bp; wild-type 
lacp); lanes 3 and 4, PvuII-BamHI fragment from pRS3220 (262 bp; 
VBdacp); lanes 5 and 6, SalI fragment from pRS9902 (350 bp; VBI 
19:lacp). Lanes 1, 3 and 5, no protein; lanes 2, 4 and 6, 1.0 pug VnG 
protein. R, retarded band. 
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Fig. 4. Effect of 3’ and 5’ sequences on VirG binding. (A) Binding of 
the VirG protein to the wild type virE promoter and to mutated virE 
promoters. Lanes 1 and 2, San-AvaII fragment from plasmid pSG675 
(250 bp, wild-type promoter); lane 3, SaKAvaII fragment from plas- 
mid pRS2013 (238 bp, deleted vir box); lane 4, Su&AvaII fragment 
from plasmid pRS3324 (250 bp, vir box inverted). Lane 1, no protein; 
lanes 24, 1.0 pg VirG protein. R, retarded band. (B) Binding of the 
VirG protein to the wild-type virA promoter and to a mutated virA 
promoter. Lanes 1 and 2, XmnI-XhoI fragment from plasmid pSW169 
(228 bp, wild-type promoter); lanes 3 and 4, XmnI-Xhol fragment from 
plasmid pRS3407 (215 bp, 13 bp downstream of the vir box deleted). 
Lanes 1 and 3, no protein; lanes 2 and 4, 1.0 pg VirG protein. R, 
retarded band. 
virE promoter where the orientation of the vir box has 
been inverted at the wild type position. The gel retarda- 
tion experiment shown in Fig. 4A reveals that VirG was 
unable to bind to fragments with this construct (lane 4) 
indicating that the vir box with 3’ and 5’ sequences differ- 
ent from the 3’ and 5’ wild type sequences is not recog- 
nized by VirG. In a further construct we deleted 13 bps 
downstream of the virA vir box. The finding that VirG 
did not bind to this construct, as shown in Fig. 4B, lane 
4, provides additional proof that specific sequences 3’ of 
the vir box are necessary for VirG binding. 
3.2. The VirG binding site is sufjcient to activate the lac 
promoter in response to plant signal molecules in 
A. tumefaciens 
We further analyzed whether the identified VirG bind- 
ing site (T/B/19 sequence) could function as a cis-acting 
regulatory sequence of a heterologous promoter. To ad- 
dress this question we tested whether the VirG binding 
site was sufficient to activate the E. coli lac promoter in 
response to the plant signal molecule acetosyringone. 
The lac promoter is constitutively expressed in A. tume- 
faciens and the level of 1acZ expression is affected neither 
by IPTG (not shown) nor by acetosyringone (Fig. 6, 
column no. 1). 
In addition to the lac promoter constructs described 
above (VB:lacp, VBl19:lacp) we used an additional con- 
trol construct where a fragment with the VB/5 sequence 
at the 3’ end, which is not sufficient for VirG binding, 
was inserted into the lac promoter. As described in sec- 
tion 2 the different promoter constructs were subcloned 
into broad host range plasmids and fused with the 1acZ 
coding regions. Expression of the 1acZ gene under con- 
trol of the modified lac promoters with and without ace- 
tosyringone was measured in A. tumefaciens strain A348. 
Fig. 5 shows that the presence of the vir gene fragments 
in the lac promoter decreased the constitutive expression 
of the 1acZ gene in Agrobacterium, indicating that the 
corresponding upstream region is involved in transcrip- 
tion from the lac promoter in Agrobacterium. A similar 
interference of 1acZ transcription by the presence of the 
vir box sequence has been reported by Powell and Kado 
[27]. The experiment shown in Fig. 5, column 4, shows 
that the presence of the VirG binding site (VB/19 se- 
quence) in the lac promoter resulted in a 2.5-fold induc- 
tion of the 1acZ gene in response to acetosyringone (Fig. 
6, no. 4). Although the stimulation of ZacZ expression in 
the presence of the plant signal molecule was small, it 
was highly reproducible (Standard deviation 0.124). 
Control experiments demonstrated that expression of the 
lac promoter with only the vir box sequence (pRS8501) 
or the VB/5 sequence (pRR2001), neither of which are 
substrates for VirG binding, was not stimulated by ace- 
tosyringone (Fig. 6, columns no. 2 and 3). 
Induction of the vir genes is mediated by the VirAl 
VirG two-component regulatory system. To test whether 
the induction of the lac promoter with the VirG binding 
site (T/B/19 sequence) by acetosyringone was dependant 
on both a functional virA and virG gene, the induction 
of the modified lac promoter was also assayed in A. 
tumefaciens strains with mutations in the virA gene 
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Fig. 5. Expression of the IucZ gene under control of the wildtype lac 
promoter and vir box lac promoter constructs in Agrobacterium strain 
A348 (wild-type Ti plasmid), A1030 (CA mutant), and Mx321 (virG 
mutant). No. 1, A348(pRS8501, lacp); 2, A348(pRS8401, VB:lacp); 3, 
A348(pRR2001, VB/S:lacp); 4, A348(pRS102.01, VB/lY:lucp); 5, 
A1030(pRS102.01); 6, Mx321(pRS102.01). 0, incubation without ace- 
tosyringone n , incubation in the presence of acetosyringone. 
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Fig. 6. Schematic representation of the promoter egion of the vir genes. 
The vir boxes are indicates by boxes (position according to [lo]) and the 
vir boxes required for full transcriptional activation according to [ 131 
are hatched. The palindromic sequences are indicated by arrows and 
the transcriptional start site is labeled as +l according to [28]. The 
bi?e,&al activity of the virH vir box has not yet been determined. *The 
transcriptional start site of the virH gene [30] has not been mapped. The 
number indicate the position of the 3’nucleotide of the sequence shown 
with respect o the translational start site. 
tively. Fig. 6, columns no. 5 and 6 shows that the modi- 
fied lac promoter on plasmid pRS10201 could not be 
induced by acetosyringone in the two mutated strains. 
This indicates that the induction of the modified lac pro- 
moter by acetosyringone in the wildtype strain was medi- 
ated by the VirA/VirG two component regulatory sys- 
tem. 
4. Discussion 
Although previous data strongly suggested that the vir 
bax is the VirG binding site [12,15] the present study 
reveals that the vir box is not sufficient for VirG protein 
binding and transcriptional activation in response to 
plant signal molecules. 
DNA binding assays using DNA fragments with in- 
creasing nucleotide length 3’ to the vir box demonstrate 
that the VirG binding site in the virE promoter comprises 
both the vir box as well as additional specific sequences 
which are contained within a 19 bp sequence 3’ to the vir 
box. Gel retardation control experiments with the vir box 
and virE promoter fragments ubcloned into the lac pro- 
moter rule out the possibility that VirG binding requires 
just the presence of any sequence 3’ of the vir box. The 
vir box flanked by lac promoter sequences was not recog- 
nized by VirG. The finding that VirG requires specific 
sequences downstream of the vir box is supported by the 
finding that deletion of sequences 3’ of the first virB vir 
box resulted in a loss of inducibility of the virB gene [ 1 l] 
and the observation that the VirG protein did not bind 
to the DNA fragments when sequences (13 bps) 3’ to the 
virA vir box had been deleted or when the virE vir box 
was inverted. 
It is not certain where the specificity lies in the 3’ 
region. However, the region downstream of the virE vir 
box contains a sequence of almost perfect dyad symme- 
try (22 out of 23 bp) which resides within the I/B/Z9 
sequence (Fig. 1). Sequence analysis reveals that all other 
vir gene promoters, except for virG, also contain palin- 
dromic sequences downstream of at least one of the vir 
box sequences (Fig. 6) suggesting their possible role in 
tirG binding. Pazour and Das [13] have found that in 
vir gene promoters with several vir boxes only one of the 
vir boxes is essential for expression of the corresponding 
vir gene. Fig. 6 shows that the identified palindromic 
sequences are always located only downstream of the 
one vir box which is required for full transcriptional 
activation supporting our model that these sequences are 
involved in vir gene expression. Potentially the down- 
stream sequences tabilize VirG binding and/or the lack 
of conserved sequences allows different binding affinities 
of VirG for the various vir boxes. Possible explanations 
of why the virG promoter does not have a palindromic 
sequence may be its unique dual promoter structure [14] 
and a different mechanism of transcriptional activation 
[13]. Since the palindromic sequences in the vir gene 
promoters do not share sequence homology the presence 
of a specific secondary structure in addition to the con- 
served vir box sequence may be necessary for VirG bind- 
ing. 
Since DNA binding studies of transcriptional activa- 
tors of other two component regulatory systems always 
involved large restriction fragments with the identified 
conserved sequences, it remains to be determined 
whether these putative binding sites are sufficient for 
binding of the regulatory proteins. This would be espe- 
cially interesting in the case of the putative OmpR bind- 
ing site [28], which shares a continuous stretch of 8 out 
of 12 bp with the vir box [12]. Alternatively, it may be 
possible that a unique type of binding site for VirG has 
been developed in A. tumefaciens vir genes to rule out 
nonspecific induction by other two component regula- 
tory systems (crosstalk). The reasons why the system is 
so stringently controlled could be the energy required for 
the expression of the large number of genes (~20) in the 
vir regulon. To our knowledge this is the first report 
which shows that binding of a transcriptional activator 
of a two component regulatory system requires both 
conserved and specific nonconserved sequences. Binding 
of a transcriptional activator protein to specific se- 
quences with no apparent sequence homology has also 
been reported for the OxyR protein [29]. 
Our results show that the identified binding site for the 
VirG protein is sufficient o regulate a heterologous pro- 
moter via the VirANirG signal transduction chain. The 
expression from the E. coli lac promoter, which is consti- 
tutively expressed in A. tumefaciens, could be stimulated 
2.5-fold in response to the plant signal molecule aceto- 
syringone. The low level of induction of the vir box fat 
promoter fusion compared to the wildtype vir genes (9- 
to 113-fold [15]) may be explained as follows. First, the 
position of the vir box(es) is variable in the different vir 
genes. Although the VirG binding site was introduced in 
132 
the same relative position as in the virE gene, this may 
not be appropriate for the lac promoter. Second, the 
identified VirG binding site may not be sufficient for full 
induction and the specific structure of the vir gene pro- 
moter region is also important. A comparison of the 
sequence of the lac and vir gen promoters reveal that 
only the -10 region, but not the -35 region, of the vir 
genes share a consensus equence which is homologous 
to the corresponding sequence of E. coli promoters [30]. 
The variable -35 region may play a role in the induction 
of these genes. In experiments imilar to the ones re- 
ported here the binding site for the NtrC protein was 
introduced into two heterologous promoters [31]. The 
NtrC-phosphate was only able to activate transcription 
of a promoter with a binding site for the alternative 
sigma factor NtrA (nifI-Ip) but not from the lac pro- 
moter. The difference between the results of VirG and 
NtrC using the Zac promoter indicates that transcription 
of A. tumefaciens vir genes is independent of an alterna- 
tive sigma factor. This conclusion is supported by the 
finding that the VirG protein lacks the conserved se- 
quences hared by transcriptional activators of NtrA de- 
pendent operons. 
Additional studies will be necessary to compare the 
properties of the VirG binding site with other bacterial 
cis acting regulatory sequences and elucidate the molecu- 
lar mechanism of transcriptional activation using a ho- 
mologous in vitro transcription system. 
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